HSBC Holdings’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.6M Buy
100,213
+62,362
+165% +$1.44M ﹤0.01% 1476
2026
Q1
$774K Sell
37,851
-46,416
-55% -$1.05M ﹤0.01% 1996
2025
Q4
$2M Sell
84,267
-2,969
-3% -$72.3K ﹤0.01% 1568
2025
Q3
$2.15M Sell
87,236
-26,482
-23% -$570K ﹤0.01% 1474
2025
Q2
$2.55M Buy
113,718
+46,526
+69% +$1.08M ﹤0.01% 1399
2025
Q1
$1.49M Buy
67,192
+23,983
+56% +$557K ﹤0.01% 1580
2024
Q4
$844K Sell
43,209
-21,858
-34% -$433K ﹤0.01% 1890
2024
Q3
$1.19M Buy
65,067
+18,883
+41% +$360K ﹤0.01% 1616
2024
Q2
$788K Buy
46,184
+30,164
+188% +$534K ﹤0.01% 1772
2024
Q1
$314K Buy
+16,020
New +$338K ﹤0.01% 2419
2023
Q2
– Sell
-15,620
Closed -$432K – 2707
2023
Q1
$432K Buy
+15,620
New +$412K ﹤0.01% 2089
2022
Q2
– Sell
-10,475
Closed -$285K – 3405
2022
Q1
$285K Buy
+10,475
New +$247K ﹤0.01% 2786

Other funds holding PRVA

HSBC Holdings's PRVA Position: Q2 2026 in Review

HSBC Holdings increased its Privia Health (PRVA) stake by 165% in Q2 2026, buying an estimated $1.44M and bringing the position to 100,213 shares worth $2.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1476.

HSBC Holdings first reported a position in PRVA in Q1 2022 and has held it in 12 quarters since. 302 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • HSBC Holdings held 100,213 shares of Privia Health worth $2.6M as of Q2 2026.
  • HSBC Holdings bought 62,362 Privia Health shares in Q2 2026, an estimated $1.44M.
  • Privia Health made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #1476 holding.
  • HSBC Holdings first reported a position in Privia Health in Q1 2022 and has held it in 12 quarters since.
  • 302 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.